http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1779111-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1be41a6727fafedfa96ff716854a22a8
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01L3-5027
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-54306
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-54366
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-543
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01L3-00
filingDate 2005-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ec70bca060a43e5d98d1182d2ed798b
publicationDate 2007-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-1779111-A1
titleOfInvention Grading of immune responses
abstract The invention is a method for grading a polyclonal antibody response with respect to a desired 5 binding specificity. The response is provoked by an antigenic agent in a host, preferably a vertebrate host. The characteristic feature of the method comprises the steps of: (i) providing a reaction microcavity having an inlet end and an outlet end and containing a solid phase that exposes an immobilized binding structure (BS) that are capable of affinity binding antibodies (Ab) of the response, (ii) flowing a liquid sample containing antibodies of the response in the direction from the inlet end to the outlet end through the solid phase, (iii) determining the distribution of antibodies, which are captured during step (ii), along the flow direction of the solid phase, and (iv) grading the response based on the distribution determined in step (iii).
priorityDate 2004-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID775
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19900077
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87060789
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP02701
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226536629
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID171548
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226428881
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67864765
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396415
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18346272
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226429729
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12714684
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226428882
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136051445
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136267354
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399873
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP22629

Total number of triples: 31.